These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9773738)

  • 21. Hypoglycemia and insulin analogues: is there a reduction in the incidence?
    Heinemann L
    J Diabetes Complications; 1999; 13(2):105-14. PubMed ID: 10432175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.
    Annuzzi G; Del Prato S; Arcari R; Bellomo Damato A; Benzi L; Bruttomesso D; Calderini MC; Coscelli C; Fedele D; Galluzzo A; Giordano M; Giorgino R; Lapolla A; Orsini P; Pagano G; Santoro D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):168-75. PubMed ID: 11590992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lispro insulin treatment in comparison with regular human insulin in type 2 diabetic patients living in nursing homes.
    Velussi M
    Diabetes Nutr Metab; 2002 Apr; 15(2):96-100. PubMed ID: 12059098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin lispro (Humalog), the first marketed insulin analogue: indications, contraindications and need for further study.
    Puttagunta AL; Toth EL
    CMAJ; 1998 Feb; 158(4):506-11. PubMed ID: 9627564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
    Raskin P; Klaff L; Bergenstal R; Hallé JP; Donley D; Mecca T
    Diabetes Care; 2000 Nov; 23(11):1666-71. PubMed ID: 11092290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia.
    Reviriego J; Gomis R; Marañés JP; Ricart W; Hudson P; Sacristán JA
    Int J Clin Pract; 2008 Jul; 62(7):1026-32. PubMed ID: 18489577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional intensified insulin therapy with short-acting insulin analog: effects on HbA1c and frequency of severe hypoglycemia. An observational cohort study.
    Hartemann-Heurtier A; Sachon C; Masseboeuf N; Corset E; Grimaldi A
    Diabetes Metab; 2003 Feb; 29(1):53-7. PubMed ID: 12629448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similar pharmacokinetics and pharmacodynamics of rapid-acting insulin lispro products SAR342434 and US- and EU-approved Humalog in subjects with type 1 diabetes.
    Kapitza C; Nowotny I; Lehmann A; Bergmann K; Rotthaeuser B; Nosek L; Becker RHA
    Diabetes Obes Metab; 2017 May; 19(5):622-627. PubMed ID: 27987252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin lispro: a review of its use in the management of diabetes mellitus.
    Simpson D; McCormack PL; Keating GM; Lyseng-Williamson KA
    Drugs; 2007; 67(3):407-34. PubMed ID: 17335298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes with insulin lispro compared with human regular insulin: a meta-analysis.
    Davey P; Grainger D; MacMillan J; Rajan N; Aristides M; Gliksman M
    Clin Ther; 1997; 19(4):656-74. PubMed ID: 9377611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin lispro: new preparation. Faster acting.
    Prescrire Int; 1998 Jun; 7(35):67-8. PubMed ID: 10342918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human insulin analogue insulin lispro.
    Koivisto VA
    Ann Med; 1998 Jun; 30(3):260-6. PubMed ID: 9677011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-year prospective audit of the effect of the introduction of insulin lispro in patients with specific clinical indications.
    Chatterjee S; Gallen IW; Sandler L
    Diabetes Care; 1999 Jul; 22(7):1226-7. PubMed ID: 10389002
    [No Abstract]   [Full Text] [Related]  

  • 34. The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes.
    Chase HP; Lockspeiser T; Peery B; Shepherd M; MacKenzie T; Anderson J; Garg SK
    Diabetes Care; 2001 Mar; 24(3):430-4. PubMed ID: 11289463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lispro insulin in type 1 diabetic patients on a Mediterranean or normal diet: a randomized, cross-over comparative study with regular insulin.
    Provenzano C; Vero R; Oliva A; Leto G; Puccio L; Vecci E; Mattioli PL; Di Mario U
    Diabetes Nutr Metab; 2001 Jun; 14(3):133-9. PubMed ID: 11476360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro.
    Loukovaara S; Immonen I; Teramo KA; Kaaja R
    Diabetes Care; 2003 Apr; 26(4):1193-8. PubMed ID: 12663596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Insulin Lispro (Lys B28, Pro B29) treatment in adolescents and young people with type 1 diabetes].
    Tuset Castellano MJ; Martínez Badás I; Alonso Blanco M; Barrio Castellanos R
    An Esp Pediatr; 2000 Apr; 52(4):334-8. PubMed ID: 11003924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin lispro update.
    Meece JD; Campbell RK
    Diabetes Educ; 2002; 28(2):269-77. PubMed ID: 11924304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Conversion of fast insulin intensive therapy to lispro insulin in type I diabetes. Pharmacoeconomic analysis of cost-effectiveness].
    Costa Pinel B; Belmonte Serrano M; Páez Vives F; Sabaté Obiol A; Estopá Sánchez A; Borrás Borrás J
    Rev Clin Esp; 2001 Aug; 201(8):448-54. PubMed ID: 11599156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction.
    Janssen MM; Snoek FJ; Masurel N; Hoogma RP; Devillé WL; Popp-Snijders C; Heine RJ
    Diabetes Care; 2000 May; 23(5):629-33. PubMed ID: 10834421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.